Searched for: in-biosketch:yes
person:rotroj01
Scopolamine and olfactory function
Serby M; Flicker C; Rypma B; Weber S; Rotrosen JP; Ferris SH
PMID: 2165425
ISSN: 0006-3223
CID: 23569
Disorders of decision in affective disease: an effect of beta-adrenergic dysfunction?
Corwin J; Peselow E; Feenan K; Rotrosen J; Fieve R
We investigated response bias (defined as the decision rule subjects adopt when uncertain) in two experiments using a variant of Signal Detection Theory (SDT) with the discrimination measure d'L and the bias measure CL, under which it is possible to independently evaluate discrimination and response bias. In the first experiment, manics, depressed subjects, and matched psychiatrically normal controls were tested with a recognition memory task with easier and more difficult components before and after 1 month of appropriate pharmacological treatment. This experiment showed that abnormally conservative bias was characteristic of depression and liberal (yea-saying) bias was found in mania regardless of severity of illness; discrimination deficits were found only when symptoms were severe. After treatment, aspects of discrimination worsened in both hypomanic and depressed nonresponders whereas response bias remained unchanged in these patients. In both groups of responders, improvements in response bias were more dramatic than improvements in discrimination. In the second experiment, psychiatrically normal hypertensives were tested with a Sternberg short-term memory scanning task on and off treatment with the centrally active beta-blocker propranolol. This experiment showed that treatment with propranolol modeled the bias deficit of depression; that is, bias became more conservative. Both sets of results suggest that disorders of decision may be modulated by beta-adrenergic function
PMID: 2158825
ISSN: 0006-3223
CID: 23590
Psychological and behavioral impact among intravenous drug users of learning HIV test results
Casadonte PP; Des Jarlais DC; Friedman SR; Rotrosen JP
In 1984 as part of a New York City study to examine the prevalence of HIV infection in a substance-abusing population and to test the validity of HIV screening kits, 94 patients at the New York VAMC were tested. Results were made available to 50 (35 seronegative, 15 seropositive) patients in January 1986. Psychological and behavioral impact of learning test results was assessed using standardized psychiatric rating scales. A comparison group of 31 nontested subjects were also evaluated. Ratings were done preresults, approximately 1-2 weeks after results, and 8-10 weeks after informing patients of their HIV status. No major stress reactions were observed. Seropositives experienced a higher level of anxiety 1-2 weeks after learning results but anxiety generally diminished; they made significant behavior changes which were maintained. Seronegatives experienced relief and maintained IV drug risk reduction behavior. Anxiety about contracting AIDS increased in nontested subjects as the study progressed
PMID: 2246090
ISSN: 0020-773x
CID: 21390
Basal ganglia calcification in schizophrenia [Letter]
Fernandez-Bouzas A; Angrist B; Hemdal P; Adler LA; Rotrosen J
PMID: 2322632
ISSN: 0006-3223
CID: 23591
Metoprolol versus propranolol
Adler LA; Angrist B; Rotrosen J
PMID: 1969753
ISSN: 0006-3223
CID: 23592
Effects of buspirone in seven schizophrenic subjects
Brody D; Adler LA; Kim T; Angrist B; Rotrosen J
PMID: 1968473
ISSN: 0271-0749
CID: 23593
ECT and Parkinson's disease revisited: a "naturalistic" study [see comments] [Comment]
Douyon R; Serby M; Klutchko B; Rotrosen J
In an open study, seven patients with Parkinson's disease received ECT for major depression. Both the motor dysfunction and the mood impairment of these patients improved following an average of seven ECT sessions. Significant improvement in motor function occurred after only two treatments. All aspects of Parkinson's disease improved significantly after ECT. Older patients showed greater improvement in motor function. The authors conclude that the therapeutic utility of ECT in depressed and nondepressed patients with Parkinson's disease should be further evaluated
PMID: 2817117
ISSN: 0002-953x
CID: 10430
NEUROLEPTIC-INDUCED AKATHISIA - REPLY [Letter]
Adler, LA; Angrist, B; Reiter, S; Rotrosen, J
ISI:A1989AJ50400026
ISSN: 0033-3158
CID: 31790
Treatment of extrapyramidal side-effects [Comment]
Adler LA; Duncan E; Reiter S; Rotrosen J; Angrist B
PMID: 2574614
ISSN: 0007-1250
CID: 23594
Efficacy of low-dose metoprolol in neuroleptic-induced akathisia
Kim A; Adler L; Angrist B; Rotrosen J
Recent studies have shown that the beta-blockers can be effective treatments for neuroleptic-induced akathisia. However, the relative contributions of beta-1 versus beta-2 blockade to the therapeutic effect of beta-blockers remains unclear. We treated nine patients who had neuroleptic-induced akathisia with low doses (25-100 mg/day) of the beta-blocker metoprolol. At these doses metoprolol causes selective blockade of beta-1 receptors. Seven patients improved after metoprolol; no further substantial changes were seen after subsequent treatment with propranolol. This finding suggests that neuroleptic-induced akathisia can be improved by selective beta-1 blockade
PMID: 2570088
ISSN: 0271-0749
CID: 23595